Graph AI, a life sciences technology company specializing in pharmacovigilance and patient safety, has raised $3 million in seed funding led by Bessemer Venture Partners. The funding will be used to expand its engineering team, accelerate product innovation, and scale enterprise adoption globally.
Founded in 2024 by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar, Graph AI operates in the fast-growing $8 billion pharmacovigilance market, which involves monitoring and managing adverse drug events (ADEs) across a drug’s lifecycle.
Pharmaceutical companies today face challenges in processing safety data spread across multiple unstructured sources — from clinical reports and call transcripts to legal filings and scientific literature. Graph AI addresses this complexity through its flagship platform, Graph Safety, which leverages artificial intelligence and intelligent automation to streamline ADE case processing, signal detection, compliance, and reporting.
By automating manual workflows, the platform minimizes human intervention to only the regulatory-mandated steps, ensuring faster, more accurate case handling. It centralizes safety data for real-time analysis and audit readiness, improving both the speed and reliability of pharmacovigilance operations.
Early enterprise clients have reported substantial efficiency gains, faster compliance cycles, and higher accuracy in medical reviews after integrating Graph Safety into their systems.
The startup’s team brings deep industry experience from Infosys, LTI Mindtree, ServiceNow, Google, and Cisco, combining domain expertise with advanced technology capabilities. As Graph AI scales, it plans to leverage its growing traction across a pipeline of more than 7,000 marketed drugs, targeting major pharmaceutical and biotech firms.
Final Take:
By automating the complex world of drug safety monitoring, Graph AI is poised to transform how global pharma companies ensure patient safety and regulatory compliance.
Keep building. Keep learning. Keep growing with StartupByDoc.

